Dr Reddy's Laboratories has relaunched its esomeprazole magnesium delayed-release capsules, a therapeutic equivalent generic version of Nexium (esomeprazole magnesium) delayed-release capsules in the US market. With this news, DRL scrip closed higher by Rs.19.10 to Rs.3121.40 today on BSE.
Nexium is a registered trademark of AstraZeneca AB Corporation.